Literature DB >> 12130725

Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease.

Lu Liu1, Fei Shang, Irit Markus, Elizabeth Burcher.   

Abstract

The characteristics of [(125)I]Bolton-Hunter[Sar(9),Met(O(2))(11)]substance P ([(125)I]BH-SarSP) binding were investigated in membranes of human ascending, transverse, distal, and sigmoid colon circular muscle. Binding of [(125)I]BH-SarSP was of high affinity (K(D) = 68 nM) and low capacity (B(max) = 0.31 fmol/mg of wet weight tissue), and showed no regional differences. [(125)I]BH-SarSP binding was inhibited by SP approximately equal to [Pro(9)]SP > or = (2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine (CP99994) >> neurokinin (NK) A > or = neuropeptide gamma > [Lys(5),MeLeu(9),Nle(10)]-NKA(4-10) approximately (S)-N-methyl-N[4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl) butyl]benzamide (SR48968) >> senktide, suggesting binding to NK-1 sites. Most agonists seemed to bind to two sites. In autoradiographic studies, dense binding for [(125)I]BH-SarSP was associated with submucosal and longitudinal muscle blood vessels, and the submucosal margin of circular muscle (corresponding to interstitial cells of Cajal), with moderate binding over most of the circular muscle. In normal colon circular muscle strips, [Pro(9)]SP was almost ineffective, and SP caused contractions with pD(2) values of 5.3 to 5.7. No regional differences were observed in potency or efficacy. Responses to SP were inhibited by the NK-2 receptor antagonist SR48968, but not by NK-1 antagonist CP99994, indicating the involvement of NK-2 rather than NK-1 receptors. Atropine significantly inhibited contractions induced by SP, indicating a minor cholinergic component. Contractile responses to SP were considerably reduced in preparations from patients with diverticular disease, and marginally reduced in ulcerative colitis compared with control. This study clearly demonstrates an NK-1 binding site on human colon circular muscle, but its role in this tissue remains unclear and may not involve contractile mechanisms. The attenuated contractility in specimens with diverticular disease may reflect disease-related alterations of the tachykinin receptor system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130725     DOI: 10.1124/jpet.102.034702

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Authors:  Liying Dai; Denis W King; D Shevy Perera; David Z Lubowski; Elizabeth Burcher; Lu Liu
Journal:  Dig Dis Sci       Date:  2015-02-11       Impact factor: 3.199

Review 2.  Evaluation of molecular and genetic predisposing parameters at diverticular disease of the colon.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Athina Tousia; George Chatzopoulos; Anastasia Gkiala; Athanasios Syllaios; Maximos Frountzas; Pantelis Vassiliu; Georgios E Theodoropoulos; Evangelos Felekouras
Journal:  Int J Colorectal Dis       Date:  2021-01-07       Impact factor: 2.571

3.  Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Authors:  F Guagnini; M Valenti; S Mukenge; I Matias; A Bianchetti; S Di Palo; G Ferla; V Di Marzo; T Croci
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

4.  Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes.

Authors:  Orline Bayguinov; Brian Hagen; Kenton M Sanders
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.

Authors:  Michael Wagner; Mats Stridsberg; Christer G B Peterson; Per Sangfelt; Maria Lampinen; Marie Carlson
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 6.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

7.  Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease.

Authors:  Letizia Mattii; Chiara Ippolito; Cristina Segnani; Barbara Battolla; Rocchina Colucci; Amelio Dolfi; Gabrio Bassotti; Corrado Blandizzi; Nunzia Bernardini
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis.

Authors:  Chiara Ippolito; Cristina Segnani; Mariella Errede; Daniela Virgintino; Rocchina Colucci; Matteo Fornai; Luca Antonioli; Corrado Blandizzi; Amelio Dolfi; Nunzia Bernardini
Journal:  J Cell Mol Med       Date:  2014-12-17       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.